Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants

The new coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic, which so far has caused over 6 million deaths in 2 years, despite new vaccines and antiviral medications. Drug repurposing, an approach for the potential application of existing pharmaceutical products to new therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Iaconis, Daniela, Bordi, Licia, Matusali, Giulia, Talarico, Carmine, Manelfi, Candida, Cesta, Maria Candida, Zippoli, Mara, Caccuri, Francesca, Bugatti, Antonella, Zani, Alberto, Filippini, Federica, Scorzolini, Laura, Gobbi, Marco, Beeg, Marten, Piotti, Arianna, Montopoli, Monica, Cocetta, Veronica, Bressan, Silvia, Bucci, Enrico M., Caruso, Arnaldo, Nicastri, Emanuele, Allegretti, Marcello, Beccari, Andrea R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130985/
https://www.ncbi.nlm.nih.gov/pubmed/35614039
http://dx.doi.org/10.1038/s41419-022-04961-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130985/
https://www.ncbi.nlm.nih.gov/pubmed/35614039
http://dx.doi.org/10.1038/s41419-022-04961-z

Ejemplares similares